Managing PPNAD: Surgical and Medical Options
At a Glance
For PPNAD causing Cushing’s syndrome, bilateral adrenalectomy is usually the definitive treatment because both adrenal glands can overproduce cortisol. After surgery, lifelong glucocorticoid and mineralocorticoid replacement, emergency planning, and specialist follow-up are required.
Treating PPNAD requires a definitive plan to stop the adrenal glands from overproducing cortisol. Because the disease typically affects both adrenal glands—even if they look normal on a scan—the most effective and common treatment is surgery to remove the glands [1][2].
The Definitive Solution: Bilateral Adrenalectomy
For most patients with overt Cushing’s syndrome caused by PPNAD, the standard of care is a bilateral adrenalectomy, which is the surgical removal of both adrenal glands [1][3].
This procedure is considered the standard approach for several reasons:
- Total Control: Since PPNAD is fundamentally a bilateral condition (meaning it involves both glands), removing both is the only way to ensure that all cortisol-producing nodules are gone [2].
- Preventing Re-operation: Choosing to remove only one gland often leads to “residual” or “persistent” disease, where the remaining gland continues to overproduce cortisol, eventually requiring a second surgery [2][4].
- Resolution: Once the source of excess cortisol is removed, the physical and psychological symptoms of Cushing’s syndrome usually begin to resolve [2].
The Choice of Unilateral Surgery
In rare, highly exceptional cases in specialized centers, a surgeon might consider a unilateral adrenalectomy (removing only one gland) [1][5]. While imaging may sometimes show one gland as larger or more active, PPNAD is usually bilateral, and imaging asymmetry does not establish one-sided disease [4]. This approach carries a high risk that the remaining gland will continue to overproduce cortisol or eventually “flare up,” leading to persistent symptoms and a return to surgery [2][6]. If you and an expert team choose this path, you must be prepared for rigorous, lifelong monitoring [7].
“Bridging” the Gap: Medical Therapies
Medications are generally not a permanent cure for PPNAD. Instead, they are used as bridge therapies—temporary measures to lower cortisol levels while you prepare for surgery or if surgery needs to be delayed [8].
These are specialist-prescribed and require monitoring:
- Ketoconazole: A steroidogenesis inhibitor that can cause serious hepatotoxicity (liver damage) and drug interactions [8].
- Metyrapone and Osilodrostat: These medications block cortisol production but can cause blood-pressure or electrolyte abnormalities and medically induced adrenal insufficiency [9].
- Clinical Use: These can be helpful for patients with severe hypercortisolism who need to be stabilized before undergoing surgery [8]. In some cases where surgery is unsuitable, doctors have used these medications for longer-term medical management [9].
Lifelong Hormone Replacement
Removing both adrenal glands means your body can no longer produce two essential types of hormones: glucocorticoids (like cortisol) and mineralocorticoids (like aldosterone) [2][10].
Following a bilateral adrenalectomy, you will need to take daily replacement medications for the rest of your life:
- Glucocorticoid Replacement: Usually taken as hydrocortisone (commonly divided into two or three doses a day), prednisone (often once or twice daily), or dexamethasone (generally once daily with little or no mineralocorticoid effect) to help mimic the body’s natural cortisol rhythm, depending on the individualized regimen [2]. These must never be stopped abruptly.
- Mineralocorticoid Replacement: Usually taken as fludrocortisone once a day to help your body balance salt and water, requiring blood-pressure and electrolyte or renin monitoring [2][10].
While the idea of lifelong medication can feel overwhelming, most patients find that managing these replacements becomes a routine part of their day. It is a trade-off: in exchange for the complex and often damaging symptoms of PPNAD, you gain a manageable condition that allows your body to return to a healthier state [2][11]. After surgery, you will work closely with an endocrinologist to fine-tune your doses, adjust outpatient medication, obtain two emergency kits, and manage travel and work plans [10].
It is important to set realistic expectations for recovery. Bilateral adrenalectomy cures the cortisol overproduction, not the underlying Carney Complex, and recovery from Cushing-related muscle weakness, bone thinning, and mood changes may take months or longer to improve.
Common questions in this guide
What is the usual surgery for PPNAD with Cushing’s syndrome?
Is removing only one adrenal gland ever an option for PPNAD?
Are medicines for PPNAD a permanent alternative to surgery?
What hormone medicines are needed after both adrenal glands are removed?
How long does recovery take after surgery for PPNAD?
What should I plan for when taking hormone replacement after adrenalectomy?
Get notified when new evidence is published on pigmented nodular adrenocortical disease, primary, 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Cushing´s syndrome due to bilateral adrenal cortical disease: Bilateral macronodular adrenal cortical disease and bilateral micronodular adrenal cortical disease.
Araujo-Castro M, Marazuela M
Frontiers in endocrinology 2022; (13()):913253 doi:10.3389/fendo.2022.913253.
PMID: 35992106 - 2
PRKAR1A-negative familial Cushing's syndrome: two case reports.
Lim LL, Kitan N, Paramasivam SS, et al.
Journal of medical case reports 2015; (9()):277 doi:10.1186/s13256-015-0757-7.
PMID: 26619967 - 3
Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing's syndrome.
Meloche-Dumas L, Mercier F, Lacroix A
Best practice & research. Clinical endocrinology & metabolism 2021; (35(2)):101486 doi:10.1016/j.beem.2021.101486.
PMID: 33637447 - 4
Atypical Presentation and Course of ACTH-Independent Cushing’s Syndrome in Two Families
Yüksek Acınıklı K, Acar S, Paketçi A, et al.
Journal of clinical research in pediatric endocrinology 2026; (18(1)):169-175 doi:10.4274/jcrpe.galenos.2023.2023-9-15.
PMID: 38084047 - 5
Unilateral Adrenalectomy Could Be a Valid Option for Primary Nodular Adrenal Disease: Evidence From Twins.
Kyrilli A, Lytrivi M, Bouquegneau MS, et al.
Journal of the Endocrine Society 2019; (3(1)):129-134 doi:10.1210/js.2018-00261.
PMID: 30591956 - 6
Adrenal gland volume measurement could assist surgery option in patients with primary pigmented nodular adrenocortical disease.
Chen T, Shen S, Tang Y, et al.
Surgery 2025; (186()):109544 doi:10.1016/j.surg.2025.109544.
PMID: 40651272 - 7
Unilateral or bilateral adrenalectomy in PPNAD: six cases from a single family followed up over 40 years.
Vitellius G, Donadille B, Decoudier B, et al.
Endocrine 2022; (78(1)):201-204 doi:10.1007/s12020-022-03142-4.
PMID: 35925470 - 8
Treatment of Primary Pigmented Nodular Adrenocortical Disease.
Liu X, Zhang S, Guo Y, et al.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2022; (54(11)):721-730 doi:10.1055/a-1948-6990.
PMID: 36130700 - 9
Adrenal Cushing Syndrome: Diagnosis and Management in a 10-Year-Old Boy with Carney Complex.
Corica D, Corica D, Lugarà C, et al.
Hormone research in paediatrics 2025; (98(6)):612-621 doi:10.1159/000540691.
PMID: 39102796 - 10
Adrenal Cushing's syndrome in children.
Guarnotta V, Emanuele F, Salzillo R, Giordano C
Frontiers in endocrinology 2023; (14()):1329082 doi:10.3389/fendo.2023.1329082.
PMID: 38192416 - 11
Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management.
Tulelli B, Besançon A, Stoupa A, et al.
European journal of endocrinology 2024; (191(6)):646-657 doi:10.1093/ejendo/lvae158.
PMID: 39676528
This page explains PPNAD surgery, cortisol-lowering medicines, and hormone replacement for informational purposes only; it does not constitute medical advice. An endocrinologist and endocrine surgeon should help you choose treatment and monitor your hormone needs.